Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM
M Mieresova, K Balazova, J Kubele… - Clinical Case …, 2023 - Wiley Online Library
The aim of this article is to demonstrate extreme interindividual variability of
piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients …
piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients …
Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One-Centre experience with TDM
M Mieresova, K Balazova, J Kubele… - Clinical Case …, 2023 - search.proquest.com
The aim of this article is to demonstrate extreme interindividual variability of
piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients …
piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients …
[HTML][HTML] Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM
M Mieresova, K Balazova, J Kubele, D Cerny… - Clinical Case …, 2023 - ncbi.nlm.nih.gov
The aim of this article is to demonstrate extreme interindividual variability of
piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients …
piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients …
Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One-Centre experience with TDM
M Mieresova, K Balazova, J Kubele… - Clinical case …, 2023 - pubmed.ncbi.nlm.nih.gov
The aim of this article is to demonstrate extreme interindividual variability of
piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients …
piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients …
Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One‐Centre experience with TDM
M Mieresova, K Balazova, J Kubele, D Cerny… - Clinical Case …, 2023 - europepmc.org
The aim of this article is to demonstrate extreme interindividual variability of
piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients …
piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients …
Piperacillin/Tazobactam in critically ill morbidly obese patients: A case series: The first One-Centre experience with TDM.
M Mieresova, K Balazova, J Kubele, D Cerny… - Clinical Case …, 2023 - europepmc.org
The aim of this article is to demonstrate extreme interindividual variability of
piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients …
piperacilin/tazobactam (PIP/TAZO) pharmacokinetics in critically ill morbidly obese patients …